Viewing Study NCT06102759


Ignite Creation Date: 2025-12-24 @ 3:03 PM
Ignite Modification Date: 2025-12-27 @ 1:01 AM
Study NCT ID: NCT06102759
Status: RECRUITING
Last Update Posted: 2023-10-26
First Post: 2023-10-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Advanced Gastric Cancer After PD-1 Antibody Failed
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module